You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antigen Presentation

Showing 1 - 25 of 4,716
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 1 Trial in Aurora (Methyldopa)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Aurora, Colorado
    Barbara Davis Center for Diabetes, University of Colorado School
Jan 6, 2022

Covid19 Trial in Rockville (CoronaVac® plus TICE® BCG Mix for Intradermal Injection)

Active, not recruiting
  • Covid19
  • CoronaVac® plus TICE® BCG Mix for Intradermal Injection
  • Rockville, Maryland
    MIDI Clinical Trial Sites -c/o- Dr. Han Xu - Sponsor / Investiga
Jan 12, 2022

COVID-19 Trial in Rockville (Ad26 COVID-19 Spike plus TICE® BCG Mix for Intradermal Injection)

Active, not recruiting
  • COVID-19
  • Recombinant COVID-19 Spike Protein plus TICE® BCG Mix for percutaneous use
  • Rockville, Maryland
  • +1 more
Jan 18, 2023

Covid19 Trial in North Bethesda (COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection)

Active, not recruiting
  • Covid19
  • COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection
  • North Bethesda, Maryland
    Medicine Invention Design Incorporation (MIDI) - IORG0007849
Dec 2, 2021

Parkinson's Disease

Completed
  • Parkinson's Disease
    • La Jolla, California
    • +2 more
    Feb 18, 2021

    Breast Cancer Trial in Charlottesville (Pembrolizumab, High-intensity focused ultrasound (HIFU))

    Recruiting
    • Breast Cancer
    • Charlottesville, Virginia
      University of Virginia
    Aug 11, 2021

    Type1 Diabetes Trial (Methyldopa, Placebo)

    Withdrawn
    • Type1 Diabetes Mellitus
    • (no location specified)
    Jun 26, 2020

    Solid Tumor, Hematologic Malignancy Trial in Beijing (Eliglustat, Immune checkpoint inhibitor)

    Recruiting
    • Solid Tumor
    • Hematologic Malignancy
    • Beijing, China
      Department of Biotherapeutic, Chinese PLA General Hospital
    Apr 28, 2022

    Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Cryoablation
    • Cryoablation combined with PD1 Inhibitor
    • (no location specified)
    Mar 28, 2023

    Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

    Recruiting
    • Hepatocellular Carcinoma
    • Hong Kong, Hong Kong
      Department of Clinical Oncology, Queen Mary Hospital
    Apr 10, 2023

    Healthy Trial in Worldwide (Ad26.COV2.S, Placebo)

    Completed
    • Healthy
    • Ad26.COV2.S
    • Placebo
    • Berlin, Germany
    • +12 more
    May 3, 2022

    Ulcerative Colitis Trial (2'-Fucosyllactose, Placebo)

    Not yet recruiting
    • Ulcerative Colitis
    • 2'-Fucosyllactose
    • Placebo
    • (no location specified)
    Sep 26, 2023

    Prostate Cancer Trial in Los Angeles (Intervention Session, Printed Material)

    Active, not recruiting
    • Prostate Cancer
    • Intervention Session
    • Printed Material
    • Los Angeles, California
      UCLA, Division of Cancer Prevention and Control Research
    Jul 1, 2022

    Type1 Diabetes Trial in Chula Vista, Aurora, Renton (350mg BID (700mg total daily) IMT-002, D-methyldopa, active formulation in

    Completed
    • Type1 Diabetes
    • 350mg BID (700mg total daily) IMT-002, D-methyldopa, active formulation in capsule or Placebo, microcrystalline cellulose in capsule
    • +3 more
    • Chula Vista, California
    • +2 more
    Aug 24, 2021

    COVID-19, Infections, Morality Trial in Fuzhou (Medical observation, Supportive treatment (BSC), Intensive care management)

    Recruiting
    • COVID-19
    • +3 more
    • Medical observation
    • +2 more
    • Fuzhou, Fujian, China
      The 900th Hospital of the Joint Logistic Support Force, PLA
    Jan 7, 2023

    Advanced Biliary Tract Carcinoma Trial in Shanghai (Pembrolizumab Injection [Keytruda], Lenvatinib Mesylate)

    Recruiting
    • Advanced Biliary Tract Carcinoma
    • Pembrolizumab Injection [Keytruda]
    • Lenvatinib Mesylate
    • Shanghai, Shanghai, China
    • +1 more
    Jul 19, 2022

    Recurrence After Emergency Presentation for Allergic REaction

    Recruiting
    • Anaphylaxis
    • Observational
    • Calgary, Alberta, Canada
    • +6 more
    Nov 1, 2022

    Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • Prostatic Neoplasm
    • abiraterone acetate in combination with prednisone
    • Homewood, Alabama
    • +44 more
    Jan 17, 2023

    Asthma, Allergic Trial in Boston (Bronchoscopy/BAL, Airway Brushing)

    Recruiting
    • Asthma, Allergic
    • Bronchoscopy/BAL
    • Airway Brushing
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2022

    Metastatic Nonsmall Cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Stereotactic Body Radiotherapy)

    Active, not recruiting
    • Metastatic Nonsmall Cell Lung Cancer
    • Non Small Cell Lung Cancer
    • Stereotactic Body Radiotherapy
    • Philadelphia, Pennsylvania
      Philadelphia CyberKnife
    Mar 15, 2022

    Meta-analysis of Metatrascryptome and Transcriptome of

    Not yet recruiting
    • Eosinophilic Esophagitis
    • Formalin-fixed Paraffin-embedded (FFPE) tissue samples analysis
    • Milan, Italy
      IRCCS Ospedale San Raffaele
    Oct 2, 2023

    Roles of Some Non-classic Biomarkers in Pediatric Pneumonia

    Not yet recruiting
    • Pneumonia in Children
      • (no location specified)
      Jan 25, 2023

      Malignant Melanoma Trial in Milan (Pembrolizumab)

      Recruiting
      • Malignant Melanoma
      • Pembrolizumab
      • Milan, Italy
        IEO Istituto Europeo di Oncologia
      May 12, 2022

      Serum Interleukin 10 in Patients With ITP

      Recruiting
      • Thrombocytopenia
      • Serum IL10 By ELISA
      • +2 more
      • Sohag, Egypt
        Faculty Of Medicine
      Oct 24, 2022

      Hemodialysis Complication Trial (CBC and flow cytometry test for monocyte)

      Not yet recruiting
      • Hemodialysis Complication
      • CBC and flow cytometry test for monocyte
      • (no location specified)
      May 24, 2023